R. Taylor Ripley, M.D.
Thoracic and Gastrointestinal Oncology Branch
Building 10, Room 4-3952
Bethesda, MD 20892
My clinical and research interests are in the treatment of esophageal cancer. We are evaluating the effects of environmental exposure of esophageal adenocarcinoma to determine whether epigenetic and metabolomic targets can be identified. Specifically, the efforts will focus on the activation of oncogenes and the silencing of tumor suppressors by environmental stimuli that promote tumor growth and treatment resistance.
Dr. Ripley trained in thoracic surgery at Memorial Sloan-Kettering Cancer Center with a focus in thoracic surgical oncology. Prior to thoracic surgery, he completed the Surgical Oncology Fellowship in the Surgery Branch, NCI, and trained in general surgery at the University of Colorado. He earned a medical doctorate in 2004 from Vanderbilt University.
Ripley RT, McMillan RR, Sima CS, Hasan SM, Ahmad U, Lou F, Jones DR, Rusch VW, Rizk NP, Huang J. Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma. Ann Thorac Surg. 2014;98(3):968-74.
Ripley RT, Rusch VW. Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy. Thorac Surg Clin. 2013;23(3):273-85.
Related Scientific Focus Areas
This page was last updated on October 6th, 2017